title: Ribavirin improves early responses to peginterferon through improved interferon signaling.
authors.affiliation: Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892-1800, USA.
authors.forename: Jordan J
authors.initials: JJ
authors.lastname: Feld
authors.forename: Glen A
authors.initials: GA
authors.lastname: Lutchman
authors.forename: Theo
authors.initials: T
authors.lastname: Heller
authors.forename: Koji
authors.initials: K
authors.lastname: Hara
authors.forename: Julie K
authors.initials: JK
authors.lastname: Pfeiffer
authors.forename: Richard D
authors.initials: RD
authors.lastname: Leff
authors.forename: Claudia
authors.initials: C
authors.lastname: Meek
authors.forename: Maria
authors.initials: M
authors.lastname: Rivera
authors.forename: Myung
authors.initials: M
authors.lastname: Ko
authors.forename: Christopher
authors.initials: C
authors.lastname: Koh
authors.forename: Yaron
authors.initials: Y
authors.lastname: Rotman
authors.forename: Marc G
authors.initials: MG
authors.lastname: Ghany
authors.forename: Vanessa
authors.initials: V
authors.lastname: Haynes-Williams
authors.forename: Avidan U
authors.initials: AU
authors.lastname: Neumann
authors.forename: T Jake
authors.initials: TJ
authors.lastname: Liang
authors.forename: Jay H
authors.initials: JH
authors.lastname: Hoofnagle
mesh_terms: D000328:Adult; D000368:Aged; D000998:Antiviral Agents / Q000494:pharmacology*; D054357:Chemokine CXCL10 / Q000097:blood; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000821:virology; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009154:Mutation; D011092:Polyethylene Glycols / Q000008:administration & dosage / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood; D011994:Recombinant Proteins; D012254:Ribavirin / Q000097:blood / Q000494:pharmacology*; D015398:Signal Transduction / Q000187:drug effects*; D016896:Treatment Outcome
chemical_list: D000998:Antiviral Agents; C114753:CXCL10 protein, human; D054357:Chemokine CXCL10; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; D012254:Ribavirin; C100416:peginterferon alfa-2a